Azole-resistant Candida parapsilosis complex isolates from Kayseri, Türkiye: genomic, phenotypic, antifungal resistance, and virulence characteristics
This study characterizes azole-resistant *Candida parapsilosis* complex isolates from Kayseri, Türkiye, revealing universal fluconazole resistance, high virulence potential, and diverse genetic mechanisms through whole-genome sequencing, which also confirmed the predominance of *C. parapsilosis* sensu stricto in pediatric ICU blood infections.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the human body as a bustling city, constantly patrolled by a security force called the immune system. Usually, this force keeps tiny, single-celled organisms called fungi in check. But sometimes, a specific type of fungus called Candida decides to throw a party it shouldn't, growing out of control and causing serious infections. For decades, doctors had a reliable "off switch" for these parties: a group of drugs called azoles (like fluconazole). Think of azoles as a master key that jams the fungus's fuel pump, stopping it from making the energy it needs to survive. However, in recent years, some Candida strains have learned to pick the lock or build a new fuel pump entirely, becoming "resistant." When this happens, the master key stops working, and the infection becomes much harder to stop, especially in vulnerable places like hospitals.
Now, enter a team of scientists from Erciyes University in Kayseri, Türkiye, who decided to investigate a particularly stubborn group of these resistant fungi. They focused on the Candida parapsilosis complex. Think of this "complex" not as a single species, but as a family of three very close cousins—C. parapsilosis, C. orthopsilosis, and C. metapsilosis—who look almost identical to the naked eye (and even to standard lab tests) but behave differently. The researchers wanted to know: Who exactly are these intruders? How did they learn to ignore the drugs? And how dangerous are they?
To solve this mystery, the team gathered 30 samples of these azole-resistant fungi from patients in Kayseri. They didn't just look at them under a microscope; they used a high-tech tool called Whole-Genome Sequencing (WGS). If standard identification is like recognizing a person by their face, WGS is like reading their entire family tree and genetic code to see exactly who they are and what secrets they carry.
Here is what they discovered:
The Identity Crisis
When the scientists used their super-precise genetic scanner, they found that while most of the samples (28 out of 30) were indeed the main cousin, C. parapsilosis sensu stricto, two of them were actually the lesser-known cousin, C. orthopsilosis. This was a big deal because standard lab tests had missed the difference. It's like realizing two people wearing the same uniform are actually from different regiments, which matters because they might have different strengths and weaknesses.
The "Where" and "Who"
The story of these infections was mostly a hospital drama. A whopping 84% of the patients were in Intensive Care Units (ICUs), and the majority of those were children. Blood was the most common place the fungus was found (90% of the time). The researchers noted that these patients often had tubes and catheters, which the fungus seems to love.
The Drug Resistance
The news here is tough. Every single one of these 30 fungal strains was completely resistant to fluconazole and itraconazole. That's a 100% failure rate for those specific drugs. Even worse, 70% of them were also resistant to voriconazole, another strong drug in the same family. However, there was a silver lining: the fungi were still vulnerable to two other types of drugs, amphotericin B and caspofungin. It's as if the fungus built a wall against the azole family, but left the back door open for these other two.
The Secret Weapons (Virulence)
Why are these fungi so good at causing trouble? The team looked at their "weapons." They found that the main cousin (C. parapsilosis) was a master builder of biofilms. Imagine a biofilm as a sticky, slimy fortress the fungus builds on medical devices or inside the body; it protects the fungus from drugs and the immune system. About 78.6% of the main cousins could build these fortresses. They also produced high levels of "proteinase" (92.8%), which is like a pair of molecular scissors that helps the fungus cut through human tissue. Interestingly, the two C. orthopsilosis cousins were different: they could make the scissors but couldn't build the sticky fortress.
The Genetic Clues
The scientists then looked inside the fungi's DNA to find out how they became so resistant. They expected to find a specific mutation in a gene called ERG11, which is the usual suspect for azole resistance. But here's the twist: only 20% of the fungi had this classic mutation. The other 80% had found other ways to cheat the system.
Instead, they found a messy mix of changes in many other genes. The most common changes were in genes like ERG3 (60%), HOG1 (56.6%), and PDR16 (53.3%). This suggests that these fungi didn't just break one lock; they rewired their entire fuel system, stress response, and defense mechanisms. It's a complex, multi-layered strategy rather than a single trick. For instance, the HOG1 gene helps the fungus handle stress, and since 56.6% of the samples had changes there, it suggests these fungi are incredibly tough survivors.
The Family Tree
Finally, the researchers drew a family tree of the fungi. They found two main groups, or "clones," named Clone A and Clone B. Clone A was the most popular, containing 17 of the 28 main cousins. While the tree showed that some fungi were closely related (suggesting they might have spread from one patient to another in the hospital), the data wasn't enough to prove a single, massive outbreak. Instead, it looked like a mix of different strains circulating in the hospital.
The Bottom Line
The study concludes that these azole-resistant fungi are a serious challenge, especially for children in ICUs. They are not just resistant because of one simple mutation; they use a complex combination of genetic tricks to survive. The fact that standard tests missed the identity of two of the strains shows that we need better, more precise tools to catch them. While the fungi are tough, the fact that they remain sensitive to amphotericin B and caspofungin offers a lifeline for doctors. However, the high rate of biofilm formation and tissue-cutting enzymes means these invaders are well-equipped to cause trouble, making early detection and the right choice of drug absolutely critical.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.